The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...

Amid current economic uncertainties, investing in defensive stocks appears as your best bet for stability, especially if a ...

Q4 2024 Earnings Call Transcript February 7, 2025 Operator: Ladies and gentlemen, thank you for standing by. Welcome to ...

Vanessa Kanu Kanu; Executive Vice President and Chief Financial Officer; Aptargroup Inc Ladies and gentlemen, thank you for standing by. Welcome to Aptar 2024 fourth quarter and annual results ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

has published its final report on Spravato (esketamine) and says the drug would need to be between 25% and 52% cheaper to meet its value threshold. The spray – which was approved by the FDA in ...

Investing in dividend aristocrats can form the cornerstone of a reliable investment strategy, owing to their qualities like ...

The Food and Drug Administration (FDA) recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...

The update is meant “to ensure that cat and dog food manufacturers are aware of information about the new H5N1 hazard associated with their pet food products,” FDA officials said. A concern ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

Thanks for following our live page today. Before we go, here's a round-up of the key developments today: Speculation continues to mount over when potential peace talks between Russia and Ukraine ...

Russia's opening gambit ahead of expected peace talks has been laid out in the media, says our Moscow correspondent Ivor Bennett. "There has been a lot of talk about potential meetings and contact ...